DAMAE Medical: Funding, Investors & Team (Sep 2026)
Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with the surface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
DAMAE Medical has raised $5.7M across 1 funding round on record, the most recent a Series A of $5.7M announced in Feb 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DAMAE Medical Company Profile and Key Stats
Latest funding round on record: Feb 2022.
DAMAE Medical Funding Rounds
DAMAE Medical Founders and Leadership Team
Contact details for the DAMAE Medical team: 1 of 1 has an email address on file.
Start 14-day free trial →DAMAE Medical Funding Compared to Other Biotechnology Startups
DAMAE Medical's latest round of $5.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DAMAE Medical in Biotechnology and Paris
Companies Similar to DAMAE Medical
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
DAMAE Medical Funding FAQs
What does DAMAE Medical do?
Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with the surface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
How much funding has DAMAE Medical raised?
DAMAE Medical has raised $5.7M across 1 round on record. The most recent is a Series A of $5.7M announced in Feb 2022.
When did DAMAE Medical last raise funding?
DAMAE Medical's most recent funding round on record is a Series A of $5.7M, announced in Feb 2022.
Who is the CEO of DAMAE Medical?
Anais Barut is listed as CEO at DAMAE Medical.
Where is DAMAE Medical headquartered?
DAMAE Medical is based in Paris, Ile-De-France, France.
How many employees does DAMAE Medical have?
DAMAE Medical is in the 11-50 employee band.
How does DAMAE Medical's funding compare to other Biotechnology startups?
DAMAE Medical's latest round of $5.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's DAMAE Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DAMAE Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.